BioCentury
ARTICLE | Company News

Cold Spring Harbor Laboratory, GlaxoSmithKline deal

April 20, 2015 7:00 AM UTC

The partners are discovering and developing small molecules to regulate the activity of protein tyrosine phosphatase 1B ( PTP-1B; PTPN1) to treat obesity and Type II diabetes. GSK and Cold Spring wi...